Literature DB >> 2478606

High mite-allergen exposure increases the risk of sensitization in atopic children and young adults.

S Lau1, G Falkenhorst, A Weber, I Werthmann, P Lind, P Buettner-Goetz, U Wahn.   

Abstract

Concentrations of major allergens of Dermatophagoides pteronyssinus (Dpt) and D. farinae (Df), Der p I and Der f I, were determined in 183 dust samples of mattresses of 133 atopic and 50 nonatopic children by a sandwich-type ELISA. Atopic children and young adults living in houses with high levels of Der p I and Der f I (greater than or equal to 2000 ng/gm of dust) were found to have significantly higher serum IgE levels to Dpt and Df (p less than 0.0001) compared to patients with low mite-allergen exposure. Washed leukocytes of 55 atopic children and 14 control subjects were investigated for in vitro histamine release to serial dilutions of Der p I; 86% of highly exposed (greater than or equal to 10,000 ng/gm) children demonstrated positive histamine release in response to Der p I compared to 17% in the group with very low exposure (less than 400 ng/gm). There was a positive correlation between basophil sensitivity (rs = 0.6; p less than 0.0001) and reactivity (rs = 0.54; p less than 0.0001) to Der p I and mite-allergen exposure. The relative risk for sensitization in the highly exposed group versus the group with very low exposure was sevenfold to 32-fold increased. We conclude that high concentrations of mite allergen (greater than or equal to 2000 ng/gm) increase the risk of specific sensitization in atopic children and young adults and thus may facilitate allergic airway disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478606     DOI: 10.1016/0091-6749(89)90300-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  20 in total

Review 1.  Epidemiology of allergic rhinitis.

Authors:  R Michael Sly
Journal:  Clin Rev Allergy Immunol       Date:  2002-02       Impact factor: 8.667

Review 2.  Pharmacotherapy of childhood asthma. An inflammatory disease.

Authors:  H P Van Bever; W J Stevens
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

Review 3.  Epidemiology of dust-mite-related disease.

Authors:  R Sporik; T A Platts-Mills
Journal:  Exp Appl Acarol       Date:  1992-11       Impact factor: 2.132

4.  Acaricidal activities of some essential oils and their monoterpenoidal constituents against house dust mite, Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).

Authors:  El-Zemity Saad; Rezk Hussien; Farok Saher; Zaitoon Ahmed
Journal:  J Zhejiang Univ Sci B       Date:  2006-12       Impact factor: 3.066

5.  Mold damage in homes and wheezing in infants.

Authors:  Seung-Hyun Cho; Tiina Reponen; Grace LeMasters; Linda Levin; Jian Huang; Teija Meklin; Patrick Ryan; Manuel Villareal; David Bernstein
Journal:  Ann Allergy Asthma Immunol       Date:  2006-10       Impact factor: 6.347

6.  Relation between response to exercise and diurnal variability of peak expiratory flow in primary school children.

Authors:  T Frischer; J Kühr; R Meinert; W Karmaus; J Forster; R Urbanek
Journal:  Thorax       Date:  1993-03       Impact factor: 9.139

7.  Insect hemoglobins (Chi tI) of the diptera family Chironomidae are relevant environmental, occupational, and hobby-related allergens.

Authors:  X Baur; V Liebers
Journal:  Int Arch Occup Environ Health       Date:  1992       Impact factor: 3.015

Review 8.  The effect of allergen exposure in early childhood on the development of atopy.

Authors:  Adnan Custovic; Clare S Murray
Journal:  Curr Allergy Asthma Rep       Date:  2002-09       Impact factor: 4.919

9.  Allergic Responses Induced by a Fungal Biopesticide Metarhizium anisopliae and House Dust Mite Are Compared in a Mouse Model.

Authors:  Marsha D W Ward; Yong Joo Chung; Lisa B Copeland; Donald L Doerfler
Journal:  J Toxicol       Date:  2011-06-21

Review 10.  Dust mite allergens: mitigation and control.

Authors:  Enrique Fernández-Caldas
Journal:  Curr Allergy Asthma Rep       Date:  2002-09       Impact factor: 4.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.